207940.KS
Samsung Biologics Co., Ltd.
₩1363000.00
-0.73%
2026-05-29
About Samsung Biologics Co., Ltd.
Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.
Key Fundamentals
Forward P/E
28.28
ROE
18.3%
Revenue Growth (YoY)
25.8%
Profit Margin
39.0%
Debt/Equity
15.08
Beta
0.26
Market Cap
₩63.09T
Avg Volume (10D)
68K
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
₩1693000.00
60D Low
₩0.00
Avg Volume
55K
Latest Close
₩1363000.00
Get breakout alerts for 207940.KS
Sign up for Breakout Scanner to receive daily notifications when 207940.KS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial.
Samsung Biologics Co., Ltd. (207940.KS) is listed on the Korea Exchange (KRX). Breakout Scanner monitors 207940.KS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. 207940.KS operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.